Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer epidemiology"
DOI: 10.1016/j.canep.2018.11.002
Abstract: There is still insufficient data about the risk-benefit profile about recommending non-aspirin, non-steroidal anti-inflammatory drugs (NA-NSAIDs) for colorectal cancer (CRC) prevention, especially in people aged 40 years or older. This study specifically addressed the association… read more here.
Keywords: analysis; non; non aspirin; aspirin non ... See more keywords
RF16 EARLY ASPIRIN NON-RESPONDERS IDENTIFICATION BY ROUTINE USE OF AGGREGOMETRY TEST IN LVAD (LEFT VENTRICLE ASSIST DEVICE) PATIENTS REDUCES THE RISK OF PUMP THROMBOSIS.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cardiovascular Medicine"
DOI: 10.2459/01.jcm.0000550033.59270.c6
Abstract: Introduction: LVAD management is really challenging since inadequate anticoagulation treatment can lead to life threatening sistuations like ischemic stroke or pump thrombosis. Main intention of our study was to investigate if early identification of aspirin… read more here.
Keywords: pump; non responders; pump thrombosis; aspirin non ... See more keywords
Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.912114
Abstract: Approximately 20% of vascular patients treated with acetyl salicylic acid (i.e., aspirin) demonstrate less than expected platelet inhibition – putting them at a four-fold increased risk of adverse cardiovascular events. Low-dose rivaroxaban (2.5 mg twice… read more here.
Keywords: aspirin; non sensitivity; aspirin non; rivaroxaban ... See more keywords